INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.

  • For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.

    In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.

  • Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.

  • Complex oncology trials require deep science, regulatory expertise, and coordination. See how integrated teams and adaptive designs speed startup, protect patients, and scale.

  • Medidata Adjudicate is part of the Medidata Clinical Cloud™, and offers a cloud-based, end-to-end solution, with easily configurable modules enabling quick setup to manage endpoint adjudication in clinical trials. Medidata Adjudicate supports investigator sites, sponsors, CROs, data managers, and the CEC in collecting, managing, organizing, adjudicating and submitting clinical endpoint data.